Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 82009-113

4 FDA label images from Quallent Pharmaceuticals Health Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82009-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure1 (Structure1)

Structure1 (Structure1)
Chemical structure diagram showing the molecular structure of metoprolol succinate, the active ingredient in the Metoprolol succinate extended-release tablets by Quallent Pharmaceuticals Health LLC.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A forest plot chart displaying results for subgroups in the MERIT-HF study. It shows relative risk and 95% confidence intervals for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization (Time to First Event), and Total Mortality or Hospitalization for Heart Failure (Time to First Event). Subgroups include demographics, clinical conditions, and heart-related metrics, comparing metoprolol succinate extended-release tablets versus placebo.*
FDA Label Image

Container25mg1 (Container25mg1)

Container25mg1 (Container25mg1)
Metoprolol succinate extended-release tablets, USP, 25 mg, film-coated and packaged in a container of 500 tablets. The label includes storage instructions at 20°C to 25°C and warnings to keep out of reach of children. Manufactured by Dr. Reddy's Laboratories Limited and labeled for Quallent Pharmaceuticals Health LLC.*
FDA Label Image

Container50mg1 (Container50mg1)

Container50mg1 (Container50mg1)
Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg, film-coated, oral dosage form, in a package containing 500 tablets. Manufactured by Dr. Reddy's Laboratories Limited, India, and labeled for Quallent Pharmaceuticals Health LLC, Cayman Islands. Includes storage instructions and a barcode with NDC 82009-114-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.